These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39155759)

  • 21. In-hospital outcomes and postdischarge mortality in patients with acute coronary syndrome and atrial fibrillation.
    Saleh M; Coleman K; Fishbein J; Gandomi A; Yang B; Kossack A; Varrias D; Jauhar R; Lasic Z; Kim M; Mihelis E; Ismail H; Sugeng L; Singh V; Epstein LM; Kuvin J; Mountantonakis SE
    Heart Rhythm; 2024 Sep; 21(9):1658-1668. PubMed ID: 38823670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Missed Opportunities to Initiate Oral Anticoagulant in Atrial Fibrillation: Insights from Australian Acute Coronary Syndrome Registries.
    Ma M; Hyun K; D'Souza M; Chew D; Brieger D
    Heart Lung Circ; 2021 Aug; 30(8):1157-1165. PubMed ID: 33642171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
    Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
    JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.
    RAF and RENO-EXTEND Investigators*
    Eur Stroke J; 2023 Sep; 8(3):722-730. PubMed ID: 37458099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.
    Lopes RD; White JA; Atar D; Keltai M; Kleiman NS; White HD; Widimsky P; Zeymer U; Giugliano RP; Tricoci P; Braunwald E; Bode C; Ohman EM; Armstrong PW; Newby LK
    Int J Cardiol; 2013 Oct; 168(3):2510-7. PubMed ID: 23578889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation.
    Fox KAA; Velentgas P; Camm AJ; Bassand JP; Fitzmaurice DA; Gersh BJ; Goldhaber SZ; Goto S; Haas S; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Dabrowski E; Luo K; Gibbs L; Kakkar AK;
    JAMA Netw Open; 2020 Feb; 3(2):e200107. PubMed ID: 32101311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation diagnosed after stroke and dementia risk: cohort study of first-ever ischaemic stroke patients aged 65 or older.
    Krawczyk M; Fridman S; Cheng Y; Fang J; Saposnik G; Sposato LA
    Europace; 2019 Dec; 21(12):1793-1801. PubMed ID: 31531673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Petersen JK; Butt JH; Yafasova A; Torp-Pedersen C; Sørensen R; Kruuse C; Vinding NE; Gundlund A; Køber L; Fosbøl EL; Østergaard L
    Eur Heart J; 2021 Nov; 42(44):4553-4561. PubMed ID: 34477838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of atrial fibrillation in acute coronary syndromes: results from the ARIAM registry.
    Almendro-Delia M; Valle-Caballero MJ; Garcia-Rubira JC; Muñoz-Calero B; Garcia-Alcantara A; Reina-Toral A; Benítez-Parejo J; Hidalgo-Urbano R;
    Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):141-8. PubMed ID: 24381097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
    Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R
    Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.
    Haller PM; Sulzgruber P; Kaufmann C; Geelhoed B; Tamargo J; Wassmann S; Schnabel RB; Westermann D; Huber K; Niessner A; Gremmel T
    Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):226-236. PubMed ID: 31198930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic strategies and outcomes in acute coronary syndrome with atrial fibrillation.
    Chamberlain AM; Gersh BJ; Mills RM; Klaskala W; Alonso A; Weston SA; Roger VL
    Am J Cardiol; 2015 Apr; 115(8):1042-8. PubMed ID: 25726381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction.
    Madsen JM; Jacobsen MR; Sabbah M; Topal DG; Jabbari R; Glinge C; Køber L; Torp-Pedersen C; Pedersen F; Sørensen R; Holmvang L; Engstrøm T; Lønborg JT
    Am Heart J; 2021 Aug; 238():89-99. PubMed ID: 33957102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
    Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation.
    Gaubert M; Resseguier N; Laine M; Bonello L; Camoin-Jau L; Paganelli F
    J Thromb Haemost; 2018 Mar; 16(3):465-473. PubMed ID: 29274198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registries.
    Montrasio G; Reiner MF; Wiencierz A; Aeschbacher S; Baumgartner C; Rodondi N; Kühne M; Moschovitis G; Preiss H; Coslovsky M; De Perna ML; Bonati LH; Conen D; Osswald S; Beer JH; Koepfli P;
    Vascul Pharmacol; 2022 Dec; 147():107120. PubMed ID: 36182083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.